Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 766, pseudogene (RN7SL766P)

Target
RN7SL766P
Molecular classification
Other (Pseudogene), Non-coding RNA, 7SL RNA family
01

Overview

RNA, 7SL, cytoplasmic 766, pseudogene (RN7SL766P) is a human pseudogene belonging to the 7SL RNA family[1]. The 7SL RNA encodes a key RNA component of the signal recognition particle (SRP), an essential ribonucleoprotein involved in directing newly synthesized secretory and membrane proteins to the endoplasmic reticulum[5]. However, RN7SL766P itself is a pseudogene, meaning it is a nonfunctional, typically noncoding sequence derived from an ancestral 7SL RNA gene that has lost its ability to produce functional RNA[1][3][7]. The majority of 7SL-related sequences in the human genome are such pseudogenes rather than functional genes[3][7]. There is no evidence that RN7SL766P is expressed at detectable levels or that it encodes a functional transcript or protein[1][3][7]. In general, some pseudogenes may modulate gene regulation through miRNA titration or other non-coding RNA mechanisms, but these phenomena are not established for RN7SL766P specifically[4][6]. RN7SL766P is not considered a therapeutic target and is not implicated as a disease gene, drug target, or biomarker.

Other names
RN7SL766P
02

Mechanism of action

None (not a drug target)

03

Biological functions

No established function (pseudogene)May act as competing endogenous RNA or miRNA decoy in rare cases (general pseudogene property)
04

Disease associations

Other (pseudogenes sometimes linked to gene regulation; no direct established disease role for RN7SL766P specifically)
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None reported

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 766, pseudogene (RN7SL766P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 766, pseudogene (RN7SL766P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call